News
-
-
COMMUNIQUÉ DE PRESSE
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Taranis Details Z-900/1300 and Underlying I-1 Intrusive Target Including 53m of Anomalous Gold
Taranis Resources Inc. reports results of drill holes Thor-246 and Thor-247 at Thor Project, indicating mineralized intrusive body with anomalous gold and multiple geochemical elements -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re plans dividend of €20 per share for 2024 and resolves share buy-back with volume of up to €2.0bn
Munich Re plans €20 dividend per share for 2024 and approves €2.0bn share buy-back program. Inside information disclosed by the Board of Management -
COMMUNIQUÉ DE PRESSE
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
Wellgistics Health, Inc. concludes IPO of 888,889 shares at $4.50 each on Nasdaq Capital Market with expected $4.0 million proceeds for healthcare and pharmaceutical services expansion
